Publications in collaboration with researchers from Hospital Universitario Reina Sofia (56)

2025

  1. Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

    Revista Espanola de Cardiologia, Vol. 78, Núm. 5, pp. 416-424

  2. Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)

    Expert review of cardiovascular therapy, Vol. 23, Núm. 1-2, pp. 45-51

  3. Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis

    Heart Failure Reviews, Vol. 30, Núm. 3, pp. 575-587

  4. Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 338-346

  5. Perioperative/Periprocedural Antithrombotic Management in Oral Health Procedures. A Prospective Observational Study

    Dentistry Journal, Vol. 13, Núm. 5

  6. Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries

    Medicina Clinica, Vol. 165, Núm. 3

  7. Spanish heart transplant registry. 36th official report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia

  8. The European Society of Cardiology quality indicators in atrial fibrillation in centers of excellence in Spain: the SEC-EXCELENTE FA registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 5, pp. 389-400

2024

  1. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure, Vol. 26, Núm. 9, pp. 1999-2007

  2. Colchicine in acutely decompensated heart failure: the COLICA trial

    European Heart Journal, Vol. 45, Núm. 45, pp. 4826-4836

  3. Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy

    Medicina Clinica, Vol. 163, Núm. 7, pp. 336-343

  4. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 701-703

  5. The European Society of Cardiology quality indicators in atrial fibrillation in centers of excellence in Spain: the SEC-EXCELENTE FA registry

    Revista Espanola de Cardiologia

  6. Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: The PANDORA study

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 266-277

2023

  1. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

    American Journal of Cardiology, Vol. 203, pp. 122-127

  2. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 9, pp. 729-738

2022

  1. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  2. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  3. Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 4

  4. Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 2, pp. 202-210